Federal and state healthcare policy changes affecting access, benefits, eligibility, and care delivery.
CMS updated the hospital price transparency “enforcement outcomes” data dictionary (July 14, 2026) and released patient-facing clarifications in June 2026 FAQs. Here’s how to read the outcome labels, what they can—and can’t—tell you about your cost, and what questions to ask before you book care.
Medicare’s ACCESS program begins July 5, 2026. It tests “outcome-aligned” payments for clinician-guided, technology-supported care for certain chronic conditions in Original Medicare—without changing your right to keep seeing other Medicare providers. Here’s what to know about eligibility, enrollment, costs to ask about, and what results are still uncertain.
Starting January 1, 2026, Medicare Advantage and Medicaid plans covered by CMS-0057-F must make prior authorization decisions faster—72 hours for urgent (expedited) requests and 7 calendar days for standard requests. CMS also requires more specific denial reasons, so patients and clinicians can respond sooner.
CMS’s hospital price transparency enforcement is tied to updated 2026 requirements, and CMS publishes enforcement outcomes in a public dataset. Here’s how to read those warnings and penalty pathways—and how to use posted prices responsibly when estimating costs.
Prior authorization delays can slow prescriptions, therapy, imaging, and procedures. New CMS timelines for many “impacted” health plans begin in 2026, with faster decisions for urgent requests—and clear denial reasons so families and clinicians know what to do next.
Starting April 1, 2026, CMS escalates enforcement of hospital price transparency requirements. If you’re uninsured or self-pay, CMS explains how the No Surprises Act good faith estimate process can help you plan—and how to dispute certain bills.
Wisconsin extended BadgerCare Plus postpartum coverage from 60 days to up to about 12 months for many full-benefit members, effective in 2026. Because the state uses an “end of the month” rule, your exact coverage end date matters—especially for follow-up care, mental health support, and treating complications that can arise months after delivery.
CMS issued an interim final rule for Medicaid “community engagement” (80 hours/month) that states generally must start by Jan. 1, 2027. Here’s who is subject, what can count toward the hours, which exemptions—including medical frailty—may apply, and what to do if your state can’t verify compliance.
Starting July 1, 2026, eligible Medicare Part D beneficiaries can access certain GLP-1 weight-loss medicines through the Medicare GLP-1 Bridge at a predictable $50/month copay, through December 31, 2027. Eligibility depends on age, BMI/health conditions, and whether someone already gets a GLP-1 through their Part D plan.
CMS says some Medicaid enrollees may be exempt from new 80-hour work rules because of medical frailty. Here’s what the rule says, what the June 29 correction changed, and what still depends on your state.
Starting July 1, 2026, some people with Medicare Part D can get certain GLP-1 weight-loss drugs for a fixed $50 monthly copay through a temporary federal program. Here’s who may qualify, which drugs are included, how prior authorization works, and what the $50 price does not do.
A new federal Medicaid work rule starts in 2026 and states generally must enforce it by January 1, 2027, but it will not apply to every enrollee. Here is who may be covered, who may be exempt, and why paperwork may matter as much as the 80-hour rule.
Not everyone on Medicaid will have to meet the new federal 80-hour monthly requirement. Here is who the rule mainly targets, who may be exempt, when states can begin, and what people can do now to protect coverage.
A new federal Medicaid rule says certain adults will have to show 80 hours a month of work, school, community service, or other qualifying activity to keep coverage, generally starting January 1, 2027. But the rule has many exemptions, and some of the biggest risks may come from paperwork, verification, and state-by-state implementation details that are still developing.
CMS’s June 2026 interim final rule sets new Medicaid community-engagement requirements for some adults, but many people may be exempt. Here’s who is likely excluded, where paperwork could still cause problems, and what readers should know before state rollouts begin in 2027.
Usually not. The new federal rule applies to certain Medicaid expansion adults, not every Medicaid enrollee. But if you are in the affected group, paperwork, renewal timing, and proof of an exemption could matter just as much as the 80-hour standard.
A new federal Medicaid rule sets 2027 work-reporting standards for some adults in expansion coverage, but many people are exempt and state systems may differ.
Hospitals must now meet updated federal price-transparency requirements that took effect in 2026, but the numbers still won’t tell every patient what they will owe. Here’s how the new files and shoppable-service displays can help — and where the limits remain.
CMS has proposed new rules that could make drug prior authorization decisions faster and more transparent for many patients and clinicians. The proposal would set 24-hour deadlines for urgent requests and 72-hour deadlines for standard requests, but it is not final yet.
CMS and HHS have announced new rural health funding, while CMS is also moving ahead with hospital price transparency updates and a proposed rule on Medicaid managed care and fee-for-service payments. For patients, the biggest near-term effects could show up in access, provider payments, and how clearly hospitals must post prices, though details will vary by state, plan, and facility.
CMS has proposed new electronic prior-authorization rules for drugs that could shorten some approval waits, but the change is not final. The plan would still need public comments, a final rule, and plan-by-plan implementation before patients see any effect.
CMS has launched a five-year rural health program that will send money to every state starting in 2026. The key question for patients is whether states use the funds to improve local care, shorten travel times, and strengthen services people can actually reach.
End of content
End of content
